Effects on the Pain of an Infiltration by Acid Hyaluronic Association and Corticoids Versus Only Corticoids in the Rhizarthrosis.

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-05-11

Study Completion Date

2021-12-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The rhizarthrosis, or the degenerative osteoarthritis of the trapezo-metacarpal joint, is a frequent degenerative osteoarthritis.

The treatment associates not pharmacological measures, such as resting relative of the joint, the orthosis of rest, glazing and pharmacological measures such analgesic, anti-inflammatory not steroidal per bones or premises, even infiltrations cortisone or by hyaluronic acid.

No study has, for the moment, tested the interest of the combination of cortisone and hyaluronic acid in rhizarthrosis. In view of the current publications, we propose to carry out a study on two arms, with corticosteroids in reference arm; the experimental arm is the combination of hyaluronic acid and cortisone.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparison of the Efficacy of Intra-articular Hybrid Hyaluronic Acid and Steroid in Patients With Rizoarthrosis

NCT03200886

Osteoarthritis Thumb

UNKNOWN

Assessment of Pain After Intra-articular Botulinum Toxin Injections in Carpometacarpal Osteoarthritis of the Thumb

NCT04829565

Rhizarthrosis

ACTIVE_NOT_RECRUITING PHASE4

Efficacy of Hyaluronic Acid and Platelet-rich Plasma Combination in Knee Osteoarthritis

NCT03211650

Knee Osteoarthritis

COMPLETED PHASE4

Chondroitin Sulphate Treatment Efficacy in Rhizarthrosis.

NCT01233739

Rhizarthrosis

UNKNOWN PHASE4

Efficacy and Safety of Intraarticular Sodium Hyaluronate Single Injection in Patients With Osteoarthritis of the Knee

NCT03852914

Osteoarthritis, Knee

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rhizarthrosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Infiltration of corticosteroids

Group Type ACTIVE_COMPARATOR

infiltration of corticosteroids

Intervention Type DRUG

infiltration of corticosteroids

Infiltration of corticosteroids and hyaluronic acid

Group Type EXPERIMENTAL

infiltration of corticosteroids and hyaluronic acid

Intervention Type DRUG

infiltration of corticosteroids and hyaluronic acid

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

infiltration of corticosteroids

Intervention Type DRUG

infiltration of corticosteroids and hyaluronic acid

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults, ≥ 40 years
* Pain located at the root of the thumb (near the wrist) and awakened by direct pressure and movement
* Pain resistant to well-conducted medical treatment, with analgesics, NSAIDs, icing with pain (analog visual scale) ≥ 4 for more than 3 months
* Radiological findings (kapandji face + profile incidence) typical of rhizarthrosis, stage II or III of Eaton and Litter, with at least 2 of the following 5 radiological elements observed on the trapeziometacarpal joint:

* marginal osteophyte
* pinching of the joint space
* sclerosis of the subchondral space
* subchondral kyst
* absence of osteopenia
* Patient with the ability to understand the protocol and signed informed consent
* Patient receiving social security

Exclusion Criteria

* Known allergy to any of the products (corticosteroids or hyaluronic acid) including its excipients (methyl parahydroxybenzoate, propyl parahydroxybenzoate, benzyl alcohol)
* Change of analgesic treatment within 4 weeks before inclusion.
* Patients with symptomatic bilateral rhizarthrosis
* Scaphoid-trapezial arthrosis
* Local or general infection
* Severe coagulation disorders, ongoing anticoagulant therapy
* severe and / or uncontrolled hypertension
* Earlier local surgery
* Associated inflammatory rheumatism
* Tendinopathy of De Quervain, thumb to jump associated
* Infiltrations earlier than 6 months
* Diabetes imbalanced
* Live vaccines
* Severe water and / or sodium retention (hypernatremia), particularly in cases of heart failure, decompensated liver failure (edema and ascites failure)
* Pregnant or lactating women
* Immunocompromised or hemodialysis patients
* Patients under guardianship, trusteeship, or deprived of liberty
* Patients participating in another clinical research protocol involving a drug or medical device
* Patients unable to follow the protocol, according to the judgment of the investigator

Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No